Currently, any product that has two-digit percentage weight loss has a chance. But Roches strategy hinges on a bet that the market will shift from an obsession with maximum weight loss to a focus on precision metabolic health, an approach where medicines are tailored to an individuals biology
But in addition to the oral compound, the branded medications, the personalized GLP-1 doses, which augment the commercially available dosages for patients that need it as well as off-patent GLP-1s like liraglutide, I think we believe the combination of that portfolio, allows customers and providers a really robust range of offerings that we think is very durable
The nearest weight loss specialist has a six-week wait and charges a monthly program fee on top of medication costs
Request a peer-to-peer review between your provider and the insurance company medical director
This approach reflects contemporary medical perspectives on sustainable weight management and reinforces the programs emphasis on consistency and oversight
doi: 10.1002/cne.24500 30 CarmichaelS